Type 2 diabetes with other specified/multiple/unspecified complications

E4_DM2NASCOMP

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 E11.6, E11.6+M14.2, E11.6+M14.6, E11.7, E11.8
Hospital discharge: ICD-9 2507A|2508A
Cause of death: ICD-10 E11.6, E11.6+M14.2, E11.6+M14.6, E11.7, E11.8
Cause of death: ICD-9 2507A|2508A
KELA reimbursements: KELA codes ANY
KELA reimbursements: ICD-10 E11

3 out of 7 registries used, show all original rules.

48030

diagram downward connector

Check minimum number of events None

48030

diagram downward connector

Include endpoints None

48030

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

46373

diagram downward connector
E4_DM2NASCOMP

Control definitions

Control exclude E4_DIABETES

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 46373 19834 26539
Unadjusted prevalence (%) 12.30 9.41 15.96
Mean age at first event (years) 61.70 61.11 62.14

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.05 3.22 [2.90, 3.58] <1e-100 7689
15 years 0.01 1.99 [1.81, 2.19] 4.2e-46 3685
5 years 0.00 3.23 [2.98, 3.50] <1e-100 2205
1 year 0.00 7.46 [6.69, 8.31] <1e-100 990

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: E4_DM2NASCOMP – Type 2 diabetes with other specified/multiple/unspecified complications
GWS hits: 215

Survival analyses between endpoints

Plot

before Type 2 diabetes with other specified/multiple/unspecified complications
after Type 2 diabetes with other specified/multiple/unspecified complications

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Type 2 diabetes with other specified/multiple/unspecified complications

Endpoint not on priority list, no data to show.